154 related articles for article (PubMed ID: 11276273)
1. Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile.
Morgan GJ; Kaine J; DeLapp R; Palmer R
J Clin Gastroenterol; 2001 Apr; 32(4):310-4. PubMed ID: 11276273
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety.
Scott DL; Palmer RH
Aliment Pharmacol Ther; 2000 Apr; 14(4):443-52. PubMed ID: 10759624
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers.
Agrawal NM; Caldwell J; Kivitz AJ; Weaver AL; Bocanegra TS; Ball J; Dhadda S; Hurley S; Hancock L
Clin Ther; 1999 Apr; 21(4):659-74. PubMed ID: 10363732
[TBL] [Abstract][Full Text] [Related]
4. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.
Weaver A; Rubin B; Caldwell J; McMahon FG; Lee D; Makarowski W; Offenberg H; Sack M; Sikes D; Trapp R
Clin Ther; 1995; 17(4):735-45. PubMed ID: 8565037
[TBL] [Abstract][Full Text] [Related]
6. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
[TBL] [Abstract][Full Text] [Related]
7. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
Fleischmann RM; Flint K; Constantine G; Kolecki B
Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
[TBL] [Abstract][Full Text] [Related]
8. Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.
Sikes DH; Agrawal NM; Zhao WW; Kent JD; Recker DP; Verburg KM
Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1101-11. PubMed ID: 12362101
[TBL] [Abstract][Full Text] [Related]
9. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee.
Makarowski W; Weaver A; Rubin B; Caldwell J; McMahon FG; Noveck RJ; Lee D; Offenberg H; Sack M; Sikes D; Trapp R; Rush S; Kuss M; Ganju J; Bocanegra TS; Ratliff JM
Clin Ther; 1996; 18(1):114-24. PubMed ID: 8851458
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
Morgan GJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
[TBL] [Abstract][Full Text] [Related]
11. Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard.
Becvár R; Urbanová Z; Vlasáková V; Vítová J; Rybár I; Maldyk H; Filipowicz-Sosnowska A; Bernacka K; Mackiewicz S; Gömör B; Rojkovich B; Siro B; Bereczki J; Toth K; Sukenik S; Green L; Ehrenfeld M; Pavelka K
Clin Rheumatol; 1999; 18(4):273-8. PubMed ID: 10468165
[TBL] [Abstract][Full Text] [Related]
12. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Eversmeyer W; Poland M; DeLapp RE; Jensen CP
Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis].
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123
[TBL] [Abstract][Full Text] [Related]
14. A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.
Roth SH; Tindall EA; Jain AK; McMahon FG; April PA; Bockow BI; Cohen SB; Fleischmann RM
Arch Intern Med; 1993 Nov; 153(22):2565-71. PubMed ID: 8239849
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee].
Gijón Baños J
Med Clin (Barc); 1997 Jun; 109(4):130-4. PubMed ID: 9289526
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
Schnitzer TJ; Ballard IM; Constantine G; McDonald P
Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of nabumetone in United States clinical trials.
Jackson RE; Mitchell FN; Brindley DA
Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
[TBL] [Abstract][Full Text] [Related]
19. A microcomputer-assisted study of nabumetone and slow release diclofenac in osteoarthritis.
Laws D; Saul S; Fehilly B
Drugs; 1990; 40 Suppl 5():29-33. PubMed ID: 2081489
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).
Reicin AS; Shapiro D; Sperling RS; Barr E; Yu Q
Am J Cardiol; 2002 Jan; 89(2):204-9. PubMed ID: 11792343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
